Cargando…
Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558771/ https://www.ncbi.nlm.nih.gov/pubmed/36244547 http://dx.doi.org/10.1016/j.jinf.2022.10.012 |
| _version_ | 1784807515887763456 |
|---|---|
| author | Cheema, Huzaifa Ahmad Jafar, Uzair Elrashedy, Asmaa Ahmed Shahid, Abia Awan, Rehmat Ullah Ehsan, Muhammad Ayyan, Muhammad Sahra, Syeda |
| author_facet | Cheema, Huzaifa Ahmad Jafar, Uzair Elrashedy, Asmaa Ahmed Shahid, Abia Awan, Rehmat Ullah Ehsan, Muhammad Ayyan, Muhammad Sahra, Syeda |
| author_sort | Cheema, Huzaifa Ahmad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9558771 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95587712022-10-16 Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis Cheema, Huzaifa Ahmad Jafar, Uzair Elrashedy, Asmaa Ahmed Shahid, Abia Awan, Rehmat Ullah Ehsan, Muhammad Ayyan, Muhammad Sahra, Syeda J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-12 2022-10-13 /pmc/articles/PMC9558771/ /pubmed/36244547 http://dx.doi.org/10.1016/j.jinf.2022.10.012 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Cheema, Huzaifa Ahmad Jafar, Uzair Elrashedy, Asmaa Ahmed Shahid, Abia Awan, Rehmat Ullah Ehsan, Muhammad Ayyan, Muhammad Sahra, Syeda Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis |
| title | Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis |
| title_full | Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis |
| title_fullStr | Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis |
| title_full_unstemmed | Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis |
| title_short | Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis |
| title_sort | efficacy and safety of fluvoxamine for the treatment of covid-19 patients: a systematic review and meta-analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558771/ https://www.ncbi.nlm.nih.gov/pubmed/36244547 http://dx.doi.org/10.1016/j.jinf.2022.10.012 |
| work_keys_str_mv | AT cheemahuzaifaahmad efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT jafaruzair efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT elrashedyasmaaahmed efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT shahidabia efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT awanrehmatullah efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT ehsanmuhammad efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT ayyanmuhammad efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis AT sahrasyeda efficacyandsafetyoffluvoxamineforthetreatmentofcovid19patientsasystematicreviewandmetaanalysis |